Published in Thromb Haemost on September 03, 2015
CALR mutation analysis is not indicated in patients with splanchnic vein thrombosis without evidence of a myeloproliferative neoplasm: a micro-review. Ann Gastroenterol (2016) 0.75
Esophageal location of mantle cell lymphoma. Ann Gastroenterol (2016) 0.75
Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease. Ther Adv Hematol (2016) 0.75
Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients. Blood Cancer J (2016) 0.75
Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic Era. Leukemia (2017) 0.75
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. Haematologica (2008) 2.46
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol (2010) 2.11
Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol (2010) 1.79
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis). Blood (2012) 1.77
Oxaliplatin-related neurotoxicity: how and why? Crit Rev Oncol Hematol (2006) 1.63
Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Thromb Haemost (2002) 1.62
Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica (2002) 1.56
Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review. Eur J Gastroenterol Hepatol (2013) 1.49
The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br J Haematol (2006) 1.47
Deletion of a 760 kb region at 4p16 determines the prenatal and postnatal growth retardation characteristic of Wolf-Hirschhorn syndrome. J Med Genet (2007) 1.45
Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. Hepatology (2013) 1.39
Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms. Blood (2013) 1.39
Two hypotheses for decreasing hepatic encephalopathy risk after transjugular intrahepatic portosystemic shunt. Hepatology (2010) 1.39
Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression. Hepatology (2014) 1.27
Chromosomal rearrangements in Xq and premature ovarian failure: mapping of 25 new cases and review of the literature. Hum Reprod (2006) 1.14
Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center. Radiology (2012) 1.12
Reciprocal translocations: a trap for cytogenetists? Hum Genet (2005) 1.12
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol (2013) 1.09
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN. Am J Hematol (2012) 1.07
Causes of adult splanchnic vein thrombosis in the mediterranean area. Mediterr J Hematol Infect Dis (2011) 1.07
Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups. Thromb Haemost (2013) 1.04
13q Deletion and central nervous system anomalies: further insights from karyotype-phenotype analyses of 14 patients. J Med Genet (2007) 1.01
19q13.11 cryptic deletion: description of two new cases and indication for a role of WTIP haploinsufficiency in hypospadias. Eur J Hum Genet (2012) 1.00
Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol (2011) 1.00
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost (2012) 0.99
Subtelomeric deletions of chromosome 9q: a novel microdeletion syndrome. Am J Med Genet A (2004) 0.99
Proteomic analysis of early urinary biomarkers of renal changes in type 2 diabetic patients. Proteomics Clin Appl (2008) 0.98
Modulating human procedural learning by cerebellar transcranial direct current stimulation. Cerebellum (2013) 0.98
Transcranial direct current stimulation: estimation of the electric field and of the current density in an anatomical human head model. IEEE Trans Biomed Eng (2011) 0.98
Educational intervention in cancer outpatient clinics on routine screening for emotional distress: an observational study. Psychooncology (2011) 0.98
The development of platinum compounds and their possible combination. Crit Rev Oncol Hematol (2006) 0.96
Elongation Factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility. Mol Cancer (2009) 0.95
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia. Haematologica (2009) 0.94
FOLFOX versus FOLFIRI: a comparison of regimens in the treatment of colorectal cancer metastases. Anticancer Res (2005) 0.94
High resolution X chromosome-specific array-CGH detects new CNVs in infertile males. PLoS One (2012) 0.94
18F-FDG-PET/CT in patients with breast cancer and rising Ca 15-3 with negative conventional imaging: a multicentre study. Eur J Radiol (2010) 0.92
Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies. Medicine (Baltimore) (2016) 0.90
A systematic review and meta-analysis of randomized trials and prospective studies comparing covered and bare self-expandable metal stents for the treatment of malignant obstruction in the digestive tract. Int J Med Sci (2013) 0.90
Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2015) 0.90
Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: A systematic review. Asia Pac J Clin Oncol (2013) 0.89
Cerebral sinus-venous thrombosis. Intern Emerg Med (2012) 0.88
Stage of portal vein thrombosis. J Hepatol (2010) 0.88
Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature. Drugs Aging (2007) 0.88
Degree of portal vein thrombosis. Hepatology (2010) 0.87
Use of the diagnostic criteria for psychosomatic research in oncology. Psychother Psychosom (2005) 0.87
Psychosocial morbidity and its correlates in cancer patients of the Mediterranean area: findings from the Southern European Psycho-Oncology Study. J Affect Disord (2004) 0.87
Anticoagulation for portal vein thrombosis in cirrhosis. Am J Med (2010) 0.87
Inherited thrombophilia, pregnancy, and oral contraceptive use: clinical implications. Semin Vasc Med (2003) 0.87
Presence of 1q gain and absence of 7p gain are new predictors of local or metastatic relapse in localized resectable neuroblastoma. Neuro Oncol (2008) 0.86
Evolutionary genomic remodelling of the human 4q subtelomere (4q35.2). BMC Evol Biol (2007) 0.86
Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation. Ann Hematol (2009) 0.86
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis. Am J Hematol (2011) 0.86
Ovarian cancer: can proteomics give new insights for therapy and diagnosis? Int J Mol Sci (2013) 0.84
Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis. Thromb Res (2012) 0.84
Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis. Hepatol Res (2013) 0.83
Affective syndromes and their screening in cancer patients with early and stable disease: Italian ICD-10 data and performance of the Distress Thermometer from the Southern European Psycho-Oncology Study (SEPOS). J Affect Disord (2008) 0.83
Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants. Blood Coagul Fibrinolysis (2008) 0.83
Quality of life in elderly cancer patients. Eur J Cancer (2007) 0.83
Gene copy number variation in male breast cancer by aCGH. Anal Cell Pathol (Amst) (2010) 0.83
The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S. Haematologica (2006) 0.83
Percutaneous transhepatic biliary metal stent for malignant hilar obstruction: results and predictive factors for efficacy in 159 patients from a single center. Cardiovasc Intervent Radiol (2014) 0.82
Identification of protein clusters predictive of response to chemotherapy in breast cancer patients. J Proteome Res (2009) 0.82
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia. Am J Hematol (2010) 0.82
Numerical estimation of the current density in the heart during transcranial direct current stimulation. Brain Stimul (2012) 0.82
Diagnostic criteria for psychosomatic research and psychosocial variables in breast cancer patients. Psychosomatics (2004) 0.82
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms. Am J Hematol (2009) 0.81
Gene copy number variation in male breast cancer by aCGH. Cell Oncol (Dordr) (2011) 0.81
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms. Br J Haematol (2008) 0.81
Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene. Haematologica (2003) 0.81
Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol (2014) 0.81
Reticulocyte hemoglobin equivalent: an indicator of reduced iron availability in chronic kidney diseases during erythropoietin therapy. Lab Hematol (2007) 0.81
The preferable treatment for cirrhotic portal vein thrombosis: anticoagulation or transjugular intrahepatic portosystemic shunt? Hepatology (2010) 0.81
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience. Strahlenther Onkol (2011) 0.80
Psychological factors affecting oncology conditions. Adv Psychosom Med (2007) 0.80
Analysis of MTHFR polymorphisms and P16 methylation and their correlation with clinical-biological features of multiple myeloma. Ann Hematol (2006) 0.80
Cryptic t(1;12)(q44;p13.3) translocation in a previously described syndrome with polymicrogyria, segregating as an apparently X-linked trait. Am J Med Genet A (2003) 0.80
Venous thromboembolism in patients with liver diseases. Intern Emerg Med (2015) 0.80
Hopelessness and related variables among cancer patients in the Southern European Psycho-Oncology Study (SEPOS). Psychosomatics (2010) 0.80
Child-Na score: a predictive model for survival in cirrhotic patients with symptomatic portal hypertension treated with TIPS. PLoS One (2013) 0.80
Stable disease in advanced colorectal cancer: therapeutic implications. Anticancer Res (2006) 0.79
Defining the phenotype associated with microduplication reciprocal to Sotos syndrome microdeletion. Am J Med Genet A (2014) 0.79
Protein expression patterns associated with advanced stage ovarian cancer. Electrophoresis (2011) 0.79
l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol (2013) 0.79
Clinical outcomes of the transplantation of stem cells from various human tissue sources in the management of liver cirrhosis: a systematic review and meta-analysis. Curr Stem Cell Res Ther (2015) 0.79
Effects of supportive-expressive group therapy in breast cancer patients with affective disorders: a pilot study. Psychother Psychosom (2009) 0.79
Severe infectious complications in a patient treated with rituximab for idiopathic thrombocytopenic purpura. Ann Hematol (2006) 0.79
Drug-related adverse events may predict efficacy in sorafenib therapy for hepatocellular carcinoma. Hepatology (2012) 0.79
Evaluation of the prevalence of severe hyperhomocysteinemia in adult patients with thrombosis who underwent screening for thrombophilia. Thromb Res (2013) 0.79
Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis. Eur J Gastroenterol Hepatol (2016) 0.79
Depression and serotonin transporter (5-HTTLPR) polymorphism in breast cancer patients. J Affect Disord (2010) 0.79
High prevalence of the JAK2 V617F mutation in patients with extrahepatic portal vein thrombosis. Hepatology (2007) 0.78
A prenatal case of duplication with terminal deletion of 5p not identified by conventional cytogenetics. Prenat Diagn (2008) 0.78
Studies on immunoregulatory and anti-tumor activities of a polysaccharide from Salvia miltiorrhiza Bunge. Carbohydr Polym (2012) 0.78
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study. Am J Hematol (2014) 0.78
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients. Br J Haematol (2012) 0.78
Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome. Leuk Res (2008) 0.78
Treatment of stage IV colorectal carcinoma in elderly patients. Crit Rev Oncol Hematol (2005) 0.78
Hepatocellular carcinoma. Lancet (2012) 0.78